Sound Stops Stress Study: Evaluating the WAVwatch Effect

This study, called the Sound Stops Stress Study, is testing a wrist-worn device called WAVwatch 2.0. This device uses 'calming' sound frequencies to help reduce stress and everyday anxiety. Researchers want to see if the WAVwatch 2.0 can truly help people feel less stressed and more satisfied with their lives. They will measure changes in your perceived stress, anxiety levels, and general life satisfaction over about four weeks. You might be able to join if you can read English, live in the US, and don't have certain skin or hearing conditions, severe anxiety, or are pregnant. The study is currently recruiting 100 participants.

Study design
This is an interventional study planning to enroll 100 participants. It is a remotely administered decentralized trial.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your stress, anxiety, and life satisfaction will be measured at 4 weeks after starting the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07281989

Sound Stops Stress Study: Evaluating the WAVwatch Effect

Recruiting
NAAll AgesInterventionalHealth services
Efforia, Inc
~100 participants
Updated 2025-12-23 on ClinicalTrials.gov
What's tested:WAVWatch 2.0

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Perceived Stress Scale (Past Week Version)
Measured over Change from baseline (Day 1-3) in perceived stress levels at 4 weeks after the start of the intervention (Day 27-33)
+3 more outcomes measured
Stress
1 sites across 1 states
New York1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Can read and understand English.
US resident.
Willing and able to follow the requirements of the protocol.

Exclusion

Individuals with skin sensitivities
Individuals with auditory conditions
Individuals with severe anxiety or mental health disorders
Pregnancy
Individuals prone to irritation or frustration
  • Perceived Stress Scale (Past Week Version)Change from baseline (Day 1-3) in perceived stress levels at 4 weeks after the start of the intervention (Day 27-33)

    The Perceived Stress Scale (Past Week Version) is a modified version of the classic stress assessment tool that evaluates stress levels based on recent experiences within the last week. This scale helps in understanding how various situations have recently affected an individual's feelings and perceived stress levels. By focusing on a shorter time frame, it provides a more immediate assessment of stress, which can be particularly useful for quickly evaluating the effectiveness of stress management strategies or interventions. The tool retains its original structure, ensuring its reliability while making it more relevant for current stress evaluation.

  • General Anxiety Disorder (GAD-7)Change from baseline (Day 1-3) in anxiety severity at 4 weeks after the start of the intervention (Day 27-33)

    The GAD-7 is a 7-item questionnaire used to assess the severity of generalized anxiety disorder (GAD) in adults. The score is based on the responses to seven questions about the frequency of common anxiety symptoms over the past two weeks.

  • NIH Toolbox® Item Bank v3.0 - General Life Satisfaction (Ages 18+)Change from baseline (Day 1-3) in general life satisfaction at 4 weeks after the start of the intervention (Day 27-33)

    This is a survey aimed at assessing the general life satisfaction of individuals aged 18 and above. Participants are asked a series of questions to which they can respond by indicating their level of agreement or disagreement.

  • Depression, Anxiety and Stress Scales (DASS-21) SurveyChange from baseline (Day 1-3) in depression, anxiety, and stress levels at 4 weeks after the start of the intervention (Day 27-33)

    The Depression, Anxiety, and Stress Scales (DASS-21) is a widely recognized psychological assessment tool designed to measure the severity of symptoms related to depression, anxiety, and stress. It consists of 21 questions that assess various emotional and psychological factors. Participants are asked to rate the frequency and intensity of their experiences over the past week. The DASS-21 survey provides a quick and reliable way for clinicians, researchers, and individuals to gauge their levels of depression, anxiety, and stress, making it a valuable instrument for mental health assessment and research.